{"timestamp": 1771600327.39571, "value": {"ticker": "TOVX", "company_name": "Theriva Biologics, Inc.", "short_name": "Theriva Biologics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 6284718, "float_shares": 33030773, "shares_outstanding": 35688349, "short_ratio": 1.83, "short_percent_of_float": 0.21280001, "shares_short": 7592849, "shares_short_prior": 12169782, "insider_percent_held": 0.02071, "institution_percent_held": 0.03779, "total_cash": 7528000, "total_debt": 2762000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 40.991, "current_ratio": 0.9, "book_value": 0.654, "price_to_book": 0.26926607, "operating_cashflow": -18478000, "free_cashflow": -5265625, "price": 0.1761, "52w_high": 1.75, "52w_low": 0.17, "avg_volume": 5252256, "avg_volume_10d": 1887620, "full_time_employees": 20, "audit_risk": 0, "overall_risk": 0}}